Admission Date:  [**2191-12-14**]              Discharge Date:   [**2191-12-16**]  Date of Birth:  [**2148-10-8**]             Sex:   M  Service: MEDICINE  Allergies: Iodine Containing Agents Classifier  Attending:[**First Name3 (LF) 2297**] Chief Complaint: Right upper extremity DVT  Major Surgical or Invasive Procedure: TPA infusion IR guided stent placement to the R SVC  History of Present Illness: Mr. [**Known lastname **] is a 43yo man with h/o lung adenoca, recurrent SVC syndrome with DVTs in R and L subclavian vein s/p several stents and throbmolysis most recently in [**1-3**] when he was treated with 3 stents to the R and L subclavian.
He returns to the hospital today after he noticed slowed venous drainage of his R arm as well as mild R shoulder/back pain which is typical for his recurrences.
He has been taking his lovenox 60mg sq [**Hospital1 **] faithfully with the last dose last night.
They performed balloon dilation of inside of R SVC stents and recanalized with slow flow.
They began TPA infusion to thrombolize clots, starting at noon with rate 1mg/hr, decreased to 0.5mg/hr at 4pm to be run overnight.
He was admitted to the ICU for monitoring while receiving TPA infusion.
Notably, during his last hospitalization in [**1-3**] for similar complaints, he was seen by thoracic surgery as well as vascular surgery to determine whether any type of venous bypass (Dr. [**First Name4 (NamePattern1) **] [**Last Name (NamePattern1) 97935**]) or resection of 1st rib (Dr. [**Last Name (STitle) **] would be indicated however it was decided to continue on his lovenox until any other recurrence before revisiting these conversations.
Stopped gefitinib this spring after discussions with Dr. [**Last Name (STitle) 3274**].Patient has had mult episodes of SVC syndrome requiring lysis and stenting on 3 occasions from [**2186**]-[**2187**].
PMH: - congenital absence of kidney  Social History: lives in [**Initials (NamePattern4) **] [**Last Name (NamePattern4) **] with wife and 3 sons works in construction/landscaping no tob, occ etoh, no drugs former tob > 40 pack years quit [**2185**]   Family History: mGF - lung ca  Physical Exam: 96.6, HR 86, 107/54, RR 21, O2 99% RA gen: NAD, pleasant, conversant, [**Location (un) 1131**] in bed HEENT: PERRLA (small), OP not injected, MMM, NCAT Neck: no LAD, supple Cor: s1s2, RRR, no r/g/m Pulm: CTAB Abd: soft, NT,ND, +bs, no HSM Ext: no c/c/e, w/w/p, R arm not grossly larger diameter than left Skin: L side of forehead with three small pink papules   Pertinent Results: [**2191-12-14**] 10:27PM   PT-12.4 PTT-33.2 INR(PT)-1.1 [**2191-12-14**] 08:05PM   FIBRINOGE-252 [**2191-12-14**] 08:20AM   WBC-3.4* RBC-4.44* HGB-13.7* HCT-38.3* MCV-86 MCH-30.8 MCHC-35.7* RDW-13.4 [**2191-12-14**] 08:20AM   CREAT-1.1 [**2191-12-14**] 08:20AM   PLT COUNT-167 .
Patent right subclavian stent with new stent placed.
Status post TPA infusion overnight, with good angiographic results.
Narrowing and possible fragmentation of the right subclavian stent as it passes between the clavicle and first rib.
Infusion catheter placed to infuse TPA and patient was admitted for overnight infusion of TPA in the ICU unit.
Brief Hospital Course: 43yo man with h/o lung adenoca s/p XRT/[**Doctor Last Name **]/taxol/gemcitabine/ gefitinib with recurrent thoracic inlet syndrome due to thrombosis of hte R (and L) SC vein s/p several stenting procedures presents with recurrent R subclavian thrombosis ballooned and now on TPA infusion.
This time has clotted through lovenox [**Hospital1 **] dosing, indicating his first real failure of therapy.
- continued TPA at 0.5mg/kg/hr from 4pm until 7am, at which time IR reevaluated the patient and placed a stent in the right SVC.
- the patient was restarted on his lovanox dose at 60mg subcutaneous, twice daily.
- vascular surgery evaluated patient and felt that patient could follow up with them as an outpatient upon discharge for question of definitive management.
no treatment at this time, as s/p XRT and chemo.
Medications on Admission: proscar 5mg po qday (for hematuria) lovenox 60 sQ [**Hospital1 **]   Discharge Medications: 1.
Finasteride 5 mg Tablet Sig: One (1) Tablet PO DAILY (Daily).
Enoxaparin 60 mg/0.6 mL Syringe Sig: One (1)  Subcutaneous Q12H (every 12 hours).
Please follow up in the Vascular Surgery clinic ([**Telephone/Fax (1) 8343**] within 3 weeks of discharge to discuss possible surgical management for repeated upper extremity venous thrombi.
Please follow up in the Vascular Surgery clinic ([**Telephone/Fax (1) 8343**] within 3 weeks of discharge to discuss possible surgical management for repeated upper extremity venous thrombi.
